The U.S. Food and Drug Administration today issued a draft guidance aimed at fostering early-stage development of medical devices within the United States. Doing early-stage development is important to help stimulate U.S.-based innovation and contribute to medical research. The guidance document contains new approaches towards early feasibility studies, which are conducted in a small number of patients early in device development, while providing appropriate human subject protections...
More...
More...